Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Aura Biosciences Inc (AURA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Aura Biosciences's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
7.89 +0.12    +1.54%
03/05 - Closed. Currency in USD ( Disclaimer )
After Hours
7.89
0.00
0.00%
21:57:08 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 100,857
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 7.86 - 8.11
Aura Biosciences 7.89 +0.12 +1.54%

Aura Biosciences Inc Company Profile

 
Get an in-depth profile of Aura Biosciences Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

89

Equity Type

ORD

Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company’s proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmette–guérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.

Contact Information

Address 80 Guest Street 5th Floor
Boston, 02135
United States
Phone 617 500 8864
Fax -

Top Executives

Name Age Since Title
Rajesh Bhikhu Parekh 63 2015 Independent Director
Karan S. Takhar 32 2021 Independent Director
David Michael Johnson 57 2021 Independent Chairman of the Board
John T. Schiller - 2021 Member of Scientific Advisory Board
Sapna Srivastava 52 2021 Independent Director
Arun D. Singh - - Scientific & Clinical Advisor
Giovanni Mariggi 37 2019 Independent Director
Elisabet de los Pinos 49 2007 Founder, CEO, President & Director
Jay S. Duker 64 - Scientific & Clinical Advisor
Evangelos S. Gragoudas - - Scientific & Clinical Advisor
Carol L. Shields - - Scientific & Clinical Advisor
Brian Marr - - Scientific & Clinical Advisor
Richard Carvajal - - Scientific & Clinical Advisor
Antony Mattessich 56 2021 Independent Director
Isaac Yi Kim - 2021 Member of Scientific Advisory Board
Seth P. Lerner - 2021 Member of Scientific Advisory Board
Gary Steinberg - 2024 Member of Scientific Advisory Board
Neal Shore - 2023 Member of Scientific Advisory Board
Andrea Apolo - 2021 Member of Scientific Advisory Board
Max Kates - 2023 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AURA Comments

Write your thoughts about Aura Biosciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email